Central Ethics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

This was the response from Higher Education Minister Blade Nzimande against allegations that he was corrupt.

Ryvu Therapeutics got full approval to conduct Phase I/II study of RVU120 (SEL120) in patients with relapsed/refractory metastatic or advanced solid tumors in Poland News provided by Share this article Share this article KRAKOW, Poland, May 28, 2021 /PRNewswire/ -- Ryvu Therapeutics (WSE: RVU), a clinical stage drug discovery and development company focusing on novel small molecule therapies that address emerging targets in oncology, announced today that its Clinical Trial Application (CTA) to commence a single-agent, open-label Phase I/II trial, investigating the safety and efficacy of RVU1...

Ryvu Therapeutics Reports First Quarter 2021 Financial Results News provided by Share this article Share this article KRAKOW, Poland, May 12, 2021 /PRNewswire/ -- Ryvu Therapeutics (WSE: RVU) reported today its first quarter 2021 financial results and provided a corporate update. "Q1 2021 was an eventful quarter for Ryvu and developments around RVU120 played a key role in it" - commented Pawel Przewiezlikowski, Chief Executive Officer of Ryvu. "We have submitted a clinical trial application to conduct a Phase I/II study of RVU120 in patients with solid tumors, and shortly after that we receiv...